An elegant, high throughput screen in a polyclonal mouse model of breast cancer heterogeneity identified specialized clones of breast cancer cells in metastatic sites that were both angiotropic and expressed Serpine2 and Slpi; gain/loss of function studies focused on these factors demonstrated they were required for VM [97]. This evidence concerns the gene SLPI and breast carcinoma.